Skip to main content

Investor RelationsWealth Management:  CA  |  UK  |  AU


Canaccord Genuity Bolsters U.S. Healthcare Investment Banking Leadership

21st July 2020

We are pleased to announce that Thomas (Tom) O’Connor has joined Canaccord Genuity as Managing Director, Co-Head of U.S. Healthcare Investment Banking.

With this development, we also announce that long-time partners Matt Steere and Eugene Rozelman will join Tom as fellow Co-Heads of our U.S. Healthcare Investment Banking group. As a leadership team, Tom, Matt and Eugene will work closely together to grow and evolve CG’s successful presence as a leading advisor to midmarket Healthcare companies, while leading their respective practice areas with distinction. 

Tom brings more than two decades of corporate finance and advisory experience to his role, principally focused in the mid-market healthcare information and technology segments. Prior to joining CG, he held senior positions at Berkery Noyes, VSS (Veronis Suhler Stevenson), and Ernst & Young. Tom received a BS in accounting from the State University at Binghamton and an MBA from Fordham University. He is also a Certified Public Accountant.

Canaccord Genuity’s Healthcare practice remains a crucial contributor to our U.S Investment Banking group, and one that is well positioned to benefit from the current environment.  Over the past year, our Healthcare team has successfully completed nearly 60 advisory and capital-raising transactions.

These appointments underscore Canaccord Genuity’s commitment to expanding coverage in our core focus areas while delivering best-in-class investment banking and advisory services to our clients. We look forward to supporting their efforts to further strengthen the profile of our leading healthcare franchise.

How can we help?

If you would like to find out more about Canaccord Genuity or any of our services, please get in touch.